Your browser doesn't support javascript.
loading
Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia.
Salimizand, Hana; Amini, Sabrieh; Abdi, Mohammad; Ghaderi, Bayazid; Azadi, Namam-Ali.
Afiliação
  • Salimizand H; Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran.
  • Amini S; Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran.
  • Abdi M; Cellular and Molecular Research Center, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran. abdi@muk.ac.ir.
  • Ghaderi B; Department of Clinical Biochemistry, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran. abdi@muk.ac.ir.
  • Azadi NA; Department of Internal Medicine, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran. bayazidg@yahoo.com.
Tumour Biol ; 37(1): 791-8, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26250462
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Mesilato de Imatinib / Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Mesilato de Imatinib / Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article